Cynosure to Present at the RBC Capital Markets Healthcare Conference
December 05 2007 - 8:47AM
PR Newswire (US)
WESTFORD, Mass., Dec. 5 /PRNewswire-FirstCall/ -- Cynosure, Inc.
(NASDAQ:CYNO), a leading developer and manufacturer of a broad
array of light-based aesthetic treatment systems, today announced
that the company will present at the RBC Capital Markets Healthcare
Conference on Wednesday, December 12, 2007 at 10:00 a.m. ET from
The Westin New York at Times Square, New York. President and Chief
Executive Officer Michael Davin and Chief Financial Officer Timothy
Baker will discuss Cynosure's business outlook, growth strategy and
recent financial results. Investors interested in listening to the
live webcast of this presentation should log on to the "Investor
Relations" section of Cynosure's website, http://www.cynosure.com/,
and click on the link labeled "Events." The presentation will be
archived on the company's website. About Cynosure, Inc. Cynosure,
Inc. develops and markets aesthetic treatment systems that are used
by physicians and other practitioners to perform non-invasive and
minimally invasive procedures to remove hair, treat vascular
lesions, rejuvenate skin through the treatment of shallow vascular
and pigmented lesions, laser lipolysis and temporarily reduce the
appearance of cellulite. Cynosure's products include a broad range
of laser and other light-based energy sources, including
Alexandrite, pulsed dye, Nd: YAG and diode lasers, as well as
intense pulsed light. Cynosure was founded in 1991. For corporate
or product information, contact Cynosure at 800-886-2966, or visit
http://www.cynosure.com/. Contact: Scott Solomon Vice President
Sharon Merrill Associates, Inc. 617.542.5300 DATASOURCE: Cynosure,
Inc. CONTACT: Scott Solomon, Vice President of Sharon Merrill
Associates, Inc., for Cynosure, Inc., +1-617-542-5300, Web site:
http://www.cynosure.com/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From May 2024 to Jun 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2023 to Jun 2024